menu search

J&j suspends sales forecast for covid vaccine, cuts profit view

Johnson & Johnson on Tuesday said it could no longer provide a forecast for sales of its COVID-19 vaccine, as vaccine hesitancy in low-income countrie...

April 19, 2022, 12:55 pm

Emmaus life sciences launches full-service telehealth solution with online access to sickle cell treatment endari

Emmaus Life Sciences Inc has announced that it has launched an innovative full-service telehealth solution with its strategic partners, including As...

April 11, 2022, 9:10 am

Emmaus life sciences presents positive study data on endari treatment in sickle cell patients

Emmaus Life Sciences Inc (OTCQX:EMMA) has announced real-world data on the company's prescription-grade L-gl...

April 7, 2022, 10:06 am

Emmaus life sciences says it is making progress in expanding access to endari as it reports fy2021 revenue of $20.6m

Emmaus Life Sciences Inc (OTCQX:EMMA) CEO Yutaka Niihara said the company has made substantial progress in expanding access to Endari for sickle cell...

April 1, 2022, 9:54 am

Why novo nordisk shares are trading higher today

The FDA has approved Novo Nordisk A/S's (NYSE: NVO) 2.0 mg dose of Ozempic (once-weekly semaglutide ...

March 29, 2022, 9:38 am

Emmaus life sciences says its endari sickle cell treatment to be added to florida medicaid's preferred drug list

Emmaus Life Sciences Inc (OTCQX:EMMA) has said the Florida Medicaid Pharmaceutical & Therapeutics Committee has approved adding Endari, the company's ...

March 29, 2022, 9:34 am

Boosh completes its purchase of beanfields to become one of the world's largest plant-based food companies

Boosh Plant-Based Brands Inc (CSE:VEGI, OTC:VGGIF) said it has completed the asset purchase agreement to acquire substantially all of the assets of Be...

February 17, 2022, 11:01 am

Boosh completes its purchase of beanfields to become one of the world's largest plant-based food companies

Boosh Plant-Based Brands Inc (CSE:VEGI, OTC:VGGIF) said it has completed the asset purchase agreement to acquire substantially all of the assets of Be...

February 17, 2022, 11:01 am

Boosh completes its purchase of beanfields to become one of the world's largest plant-based food companies

Boosh Plant-Based Brands Inc (CSE:VEGI, OTC:VGGIF) said it has completed the asset purchase agreement to acquire substantially all of the assets of Be...

February 17, 2022, 11:01 am

Sanofi's (sny) enjaymo gets fda nod for rare blood disorder

The FDA approves Sanofi's (SNY) Enjaymo for the treatment of hemolysis in adult patients with cold agglut...

February 7, 2022, 2:39 pm

Sanofi's (sny) enjaymo gets fda nod for rare blood disorder

The FDA approves Sanofi's (SNY) Enjaymo for the treatment of hemolysis in adult patients with cold agglut...

February 7, 2022, 2:39 pm

Sanofi's (sny) enjaymo gets fda nod for rare blood disorder

The FDA approves Sanofi's (SNY) Enjaymo for the treatment of hemolysis in adult patients with cold agglut...

February 7, 2022, 2:39 pm

Mrbeast has a new chocolate bar! youtube star teams with walmart on new feastables snack food line

YouTube cut-up MrBeast is teaming with Walmart Inc. (NYSE:WMT) on a new snack food line designed to offer healthier alternatives for the in-between-me...

January 30, 2022, 10:47 am

Mrbeast has a new chocolate bar! youtube star teams with walmart on new feastables snack food line

YouTube cut-up MrBeast is teaming with Walmart Inc. (NYSE:WMT) on a new snack food line designed to offer healthier alternatives for the in-between-me...

January 30, 2022, 10:47 am

Mrbeast has a new chocolate bar! youtube star teams with walmart on new feastables snack food line

YouTube cut-up MrBeast is teaming with Walmart Inc. (NYSE:WMT) on a new snack food line designed to offer healthier alternatives for the in-between-me...

January 30, 2022, 10:47 am

Zealand (zeal) ends enrollment in short bowel syndrome study

Zealand Pharma (ZEAL) completes patient enrollment in the phase III EASE-SBS 1 study evaluating glepaglut...

January 21, 2022, 1:52 pm

Zealand (zeal) ends enrollment in short bowel syndrome study

Zealand Pharma (ZEAL) completes patient enrollment in the phase III EASE-SBS 1 study evaluating glepaglut...

January 21, 2022, 1:52 pm

Zealand (zeal) ends enrollment in short bowel syndrome study

Zealand Pharma (ZEAL) completes patient enrollment in the phase III EASE-SBS 1 study evaluating glepaglut...

January 21, 2022, 1:52 pm


Search within

Pages Search Results: